Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

Bibliographic Details
Main Authors: Alberto Zambelli, Carlo Alberto Tondini
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
_version_ 1818325000626634752
author Alberto Zambelli
Carlo Alberto Tondini
author_facet Alberto Zambelli
Carlo Alberto Tondini
author_sort Alberto Zambelli
collection DOAJ
first_indexed 2024-12-13T11:37:31Z
format Article
id doaj.art-d308c45fccf04f9193ecfeaa14c8cffe
institution Directory Open Access Journal
issn 2059-7029
language English
last_indexed 2024-12-13T11:37:31Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series ESMO Open
spelling doaj.art-d308c45fccf04f9193ecfeaa14c8cffe2022-12-21T23:47:45ZengElsevierESMO Open2059-70292020-11-015Suppl 310.1136/esmoopen-2020-000836Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?Alberto Zambelli0Carlo Alberto Tondini1Department of Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
spellingShingle Alberto Zambelli
Carlo Alberto Tondini
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
ESMO Open
title Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_full Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_fullStr Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_full_unstemmed Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_short Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
title_sort can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current covid 19 outbreak in italy
url https://esmoopen.bmj.com/content/5/Suppl_3/e000836.full
work_keys_str_mv AT albertozambelli canmultigeneassayswidentheirclinicalusefulnessinearlybreastcancertreatmentchoiceduringthecurrentcovid19outbreakinitaly
AT carloalbertotondini canmultigeneassayswidentheirclinicalusefulnessinearlybreastcancertreatmentchoiceduringthecurrentcovid19outbreakinitaly